MYH11 and atherosclerosis: Identification of circulating myosin-11 by using mass spectrometric analysis and Western blotting in patients with atherosclerosis of each region, i.e., the coronary and peripheral arteries, would clarify whether myosin-11 in the blood is fragmented or full-length, and provide further information for atherosclerosis pathologies and developing a detection system.